Irritable Bowel Syndrome

As the field of gastroenterology evolves, gone are the days when a gastroenterologist is expected to meet the needs of every patient.

We have long known that our diets affect our health, but many questions remain about diet’s impact on conditions like cancer and its potential value in treating a wide variety of health conditions.

A recent study showed that restrictive diets were more effective than optimized medical treatment alone in reducing symptoms of irritable bowel syndrome.

SAN DIEGO — An investigational, point-of-care rectal expulsion device may help determine whether patients with chronic constipation will improve with pelvic floor physical therapy, according to data presented at Digestive Disease Week 2022.

SAN DIEGO — Two restrictive diets were superior in reducing symptoms compared with optimized medical treatment alone in patients with irritable bowel syndrome, according to results presented at Digestive Disease Week 2022.

SAN DIEGO — Enterosgel, a CE-certified intestinal absorbent, reduced short-term symptoms of stool consistency and abdominal pain among patients with irritable bowel syndrome with diarrhea, according to research.

Nearly half of the respondents in Salix Pharmaceutical’s annual patient perspective survey reported it was more challenging to manage their irritable bowel syndrome and chronic idiopathic constipation symptoms during the last 12 months.

April is IBS Awareness Month and highlights the importance of public awareness and health messages about the diagnosis, treatment and quality of life for patients with irritable bowel syndrome.

According to the International Foundation for Gastrointestinal Disorders, irritable bowel syndrome is estimated to effect 10% to 15% of the population worldwide, making it the most prevalent functional GI disorder.

This month’s cover story focuses on the integrated, team-based approach to managing patients with irritable bowel syndrome.